Skip to content
PeptideAgent

Telehealth providers in Washington

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Washington. What Washington requires of telehealth prescribers and pharmacies, plus verified listings.

Washington at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Washington

No verified telehealth providers serving Washington are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Washington

Washington adopted the Uniform Telehealth Act in 2024 (chapter 18.134 RCW). RCW 18.134.010 defines telehealth as synchronous or asynchronous telecommunication technology used to provide care to a patient at a different location. Under RCW 18.134.030 a practitioner-patient relationship may be established through telehealth, but not through email, instant messaging, text messaging, or fax. RCW 18.134.040 holds telehealth care to the same professional practice standards as comparable in-person care and bars disciplining authorities from adopting different standards just because care is delivered by telehealth. RCW 18.134.050 generally requires an out-of-state practitioner to hold a Washington license, with narrow exceptions for consultation and follow-up care of established patients who are temporarily in Washington. Asynchronous technology is within the definition, but because the relationship cannot be formed by messaging or a text-based exchange, whether a first prescription can rest on an asynchronous intake alone is not settled, so this record marks it as unresolved. GLP-1 medicines and the peptides in this database are not controlled substances. [2]

Compounded GLP-1 access in Washington

Because a nonresident pharmacy that compounds must supply an inspection report from an approved program to keep its Washington license, patients can confirm eligibility through the Department of Health provider credential search. [1] [4] [8]

Research use only sellers in Washington

Chapter 69.41 RCW makes it unlawful to sell, deliver, or possess a legend (prescription) drug except on a valid prescription or as otherwise authorized (RCW 69.41.030), and pharmacy distribution into Washington requires Commission licensure under chapter 18.64 RCW. [3] [6] [9]

How to check a telehealth provider in Washington

  1. Confirm the prescriber is licensed or registered to treat patients located in Washington; the telehealth rules above explain what Washington requires. [2]
  2. Ask which pharmacy will fill the prescription and check it in the Washington Pharmacy Quality Assurance Commission (Washington State Department of Health) license lookup. [1] [3] [4] [5] [7]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Washington. [3] [6] [9]

Common questions in Washington

Can I get a GLP-1 prescription in Washington through telehealth?

Yes. Under the Uniform Telehealth Act (chapter 18.134 RCW) a Washington-licensed practitioner can establish a relationship with you through telehealth and prescribe under the same standards as an in-person visit. [2]

Can a Washington telehealth relationship start over text or email?

No. RCW 18.134.030 says a practitioner-patient relationship may not be established through email, instant messaging, text messaging, or fax. [2]

Does an out-of-state telehealth prescriber need a Washington license?

Generally yes. RCW 18.134.050 requires a Washington license, with narrow exceptions for consultation, specialty assessment, or follow-up care for established patients who are temporarily in Washington. A new GLP-1 patient in Washington needs a Washington-licensed prescriber. [2]

All peptide legal questions for Washington

Sources

  1. [1]Washington Pharmacy Quality Assurance Commission (Department of Health)
  2. [2]Chapter 18.134 RCW, Uniform Telehealth Act
  3. [3]Chapter 18.64 RCW, Pharmacists
  4. [4]RCW 18.64.360, Nonresident pharmacies
  5. [5]Chapter 246-945 WAC, Pharmacy Quality Assurance Commission (including WAC 246-945-100, compounding minimum standards)
  6. [6]RCW 69.41.030, Sale, delivery, or possession of legend drug without prescription or order prohibited
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  9. [9]21 U.S.C. 331, Prohibited acts